These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31617376)

  • 1. Nitroxyl as a Potential Theranostic in the Cancer Arena.
    Sun HJ; Lee WT; Leng B; Wu ZY; Yang Y; Bian JS
    Antioxid Redox Signal; 2020 Feb; 32(5):331-349. PubMed ID: 31617376
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitroxyl (HNO): a novel redox signaling molecule.
    Kemp-Harper BK
    Antioxid Redox Signal; 2011 May; 14(9):1609-13. PubMed ID: 21299468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the chemical biology of nitroxyl (HNO) detection and generation.
    Miao Z; King SB
    Nitric Oxide; 2016 Jul; 57():1-14. PubMed ID: 27108951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.
    Sun HJ; Wu ZY; Cao L; Zhu MY; Nie XW; Huang DJ; Sun MT; Bian JS
    Pharmacol Res; 2020 Sep; 159():104961. PubMed ID: 32474086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of nitroxyl (HNO) as a pharmacological agent.
    Switzer CH; Flores-Santana W; Mancardi D; Donzelli S; Basudhar D; Ridnour LA; Miranda KM; Fukuto JM; Paolocci N; Wink DA
    Biochim Biophys Acta; 2009 Jul; 1787(7):835-40. PubMed ID: 19426703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroxyl (HNO): the Cinderella of the nitric oxide story.
    Irvine JC; Ritchie RH; Favaloro JL; Andrews KL; Widdop RE; Kemp-Harper BK
    Trends Pharmacol Sci; 2008 Dec; 29(12):601-8. PubMed ID: 18835046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.
    Shoman ME; Aly OM
    Oxid Med Cell Longev; 2016; 2016():4867124. PubMed ID: 26770654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxyl (HNO): A Possible Strategy for Fighting Cancer.
    Shoman ME; Aly OM
    Curr Top Med Chem; 2016; 16(22):2464-70. PubMed ID: 26873191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroxyl inhibits breast tumor growth and angiogenesis.
    Norris AJ; Sartippour MR; Lu M; Park T; Rao JY; Jackson MI; Fukuto JM; Brooks MN
    Int J Cancer; 2008 Apr; 122(8):1905-10. PubMed ID: 18076071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.
    Paolocci N; Jackson MI; Lopez BE; Miranda K; Tocchetti CG; Wink DA; Hobbs AJ; Fukuto JM
    Pharmacol Ther; 2007 Feb; 113(2):442-58. PubMed ID: 17222913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroxyl (HNO) as a vasoprotective signaling molecule.
    Bullen ML; Miller AA; Andrews KL; Irvine JC; Ritchie RH; Sobey CG; Kemp-Harper BK
    Antioxid Redox Signal; 2011 May; 14(9):1675-86. PubMed ID: 20673125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.
    Kemp-Harper BK; Horowitz JD; Ritchie RH
    Drugs; 2016 Sep; 76(14):1337-48. PubMed ID: 27566478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donors of HNO.
    Miranda KM; Nagasawa HT; Toscano JP
    Curr Top Med Chem; 2005; 5(7):649-64. PubMed ID: 16101426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining nitroxyl in biological systems.
    Fukuto JM; Jackson MI; Kaludercic N; Paolocci N
    Methods Enzymol; 2008; 440():411-31. PubMed ID: 18423233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.
    Kemp-Harper BK; Velagic A; Paolocci N; Horowitz JD; Ritchie RH
    Handb Exp Pharmacol; 2021; 264():311-337. PubMed ID: 32813078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroxyl (HNO): chemistry, biochemistry, and pharmacology.
    Fukuto JM; Switzer CH; Miranda KM; Wink DA
    Annu Rev Pharmacol Toxicol; 2005; 45():335-55. PubMed ID: 15822180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.
    Fukuto JM
    Br J Pharmacol; 2019 Jan; 176(2):135-146. PubMed ID: 29859009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piloty's acid derivative with improved nitroxyl-releasing characteristics.
    Aizawa K; Nakagawa H; Matsuo K; Kawai K; Ieda N; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2340-3. PubMed ID: 23489625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.
    Johnson GM; Chozinski TJ; Gallagher ES; Aspinwall CA; Miranda KM
    Free Radic Biol Med; 2014 Nov; 76():299-307. PubMed ID: 25064322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent probes for the detection of nitroxyl (HNO).
    Smulik-Izydorczyk R; Dębowska K; Pięta J; Michalski R; Marcinek A; Sikora A
    Free Radic Biol Med; 2018 Nov; 128():69-83. PubMed ID: 29704623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.